MidCurveCapital (@midwit_capital) header
MidCurveCapital (@midwit_capital) profile picture

Forward Deployed Shitposter / Just midcurving / I own 0.1% of Personalis & Prime Medicine

Bell Curve - Dead Center
Joined November 2022
🫡
this guy is outperforming every single hedge fund in existence
2
2
28
45,478
😬😬😬
Great day to be short 32.8M shares of $PRME.🙃
3
20
861
The stars are aligning for both $BEAM & $PRME.
Exciting updates on gene editing support from the U.S. Government! We didn’t plan this… but just a few hours after our conference call outlining Beam’s vision to deliver increasingly customized genetic correction therapies to patients, even more news hit
2
4
57
2,864
Great day to be short 32.8M shares of $PRME.🙃
Considering what's transpired in biotech recently, I'd probably start to panic right about now if I were short 32M shares of $PRME.
1
2
30
2,995
My body is ready! $PRME
Increased my $PRME position to 300K shares. This is one hill I'm willing to die on!
3
53
2,034
Multiple variants under one BLA. Seminal moment for $PRME & $BEAM.
Glad to be at the @RareDiseases Summit for some Breaking News.This morning I attended the Rare Disease Regulatory Roundtable, moderated by @ComstockRi54463 Assoc. Director of the FDA rare disease hub. Guest speaker #karimMikhail made an announcement about individual gene therapy. He is Director of CBER. Watch it here! Very exciting! @FDA @DCOfficial #science #innovation
5
6
2
63
5,809
This is great news for $PRME as well.
$BEAM "I think if there is a general just kind of comment that I have that I think these LNPs are really doing quite well. This is a great delivery modality where we are talking about temporary headache, fever, flush kinds of infusion reactions or lab abnormalities in return for a one-time dose that gets you potentially transformative durable efficacy like we are seeing here. It is a pretty good delivery vehicle. We are quite happy with it." —John Evans, CEO, this morning throwing shade at analysts who are obsessed with the transient side effects of LNPs at dosing vs the permanent effect of the therapy: being cured of their genetic disease.
1
1
34
1,930
We just learned that the $PRME volume spike between Oct. 6th & Oct. 9th was not short covering. Short interest as of Oct. 15th was still sitting at 32.8M shares.
2
1
2
39
3,984
Increased my $PRME position to 300K shares. This is one hill I'm willing to die on!
$1 Million in $PRME. Send it.🙃
13
1
1
68
5,878
Many people are saying. $GTLB
Replying to @JasonDClinton
Airgapped, self-managed infrastructure, automatic vulnerability remediation. $GTLB has everything it needs to dominate this next era
4
1,182
Six Seven meme bottom. The hedge is hedging. $TLT.
1
2
923
Perhaps time for a little victory lap and for taking some off the table. Thanks for playing. $GTLB
Bough a lot of $GTLB at $22.45 today and feeling sick in my stomach.
5
37
2,843
MidCurveCapital retweeted
5
292
10
3,123
35,671
$PRME all fun and games until we get a proper break out...
2
6
2
59
5,313
Let's try that again, shall we. $PRME
2
1
19
856
$1 Million in $PRME. Send it.🙃
Violating my risk limit for new positions but fuck it... Added another 50K shares of $PRME. Now holding 250K shares.
4
1
1
69
7,490
To see a world in a grain of sand...
5
862
Dunno but might be time to roll some software exposure into semis?! $IGV / $SOXX
15
1,522
I'm increasingly coming to think that @sytses might kickstarted an era of medical agency that's going to test & stun both patients, doctors & regulators alike...
1
1
8
1,027
$MRNA paper yesterday, $AZN blog today… Increasingly feels like we’re about to witness a knife fight between “Big Pharma” to secure IP rights for $PRME editing. Good time to study the $BEAM x $LLY PCSK9 deal.
5
8
1
44
3,883